Zebra Technologies enters the post-earnings stretch having delivered one of its most dramatic single-week moves in recent memory — a 30% weekly gain to $368.83 that forced five firms to revise targets upward in a single morning and left options traders sharply less defensive than they were just days ago.
The analyst reaction on August 5 tells the story of a Street that was caught underweight. Firms broadly lifted targets — Keybanc moved to $430 from $305, BNP Paribas to $455 from $370, Barclays to $410 from $346, and Needham to $410 from $345, all while holding positive ratings. Truist, the lone holdout at Hold, still raised its target to $355 from $296 — a 20% lift even from the sceptics. The consensus mean price target is now $386, barely above the current price, which means the Street is still catching up rather than leading. The bull case rests on accelerating enterprise spending momentum — Q1 revenues were up 14% year-on-year — and a diversified exposure to retail, healthcare, and logistics automation. Bears point to limited visibility on memory costs and retail IT capex cycles, and the P/E near 15x, which trails industrial tech peers.
Options positioning shifted dramatically with the earnings print. The put/call ratio dropped to 1.66, more than two standard deviations below its 20-day mean of 2.03 — the lowest defensive reading of the past year, after the ratio had been pinned near its 52-week high of 2.27 for most of July. In plain terms: the crowd that had been buying put protection aggressively all last month unwound that hedging in one session. The borrow market reinforces that picture. Availability remains loose at around 805% — meaning roughly eight shares are available to borrow for every one currently lent out — and borrowing costs are unchanged at 0.45%, a level that has barely moved in weeks. This is not a squeeze setup.
Short interest adds a more nuanced thread. At 6.6% of free float, it is a meaningful position — not trivial — and it crept up roughly 4% on the week, suggesting some shorts are adding into the rally rather than capitulating wholesale. That said, short interest fell sharply from the 10% range in early July before this quarter's earnings, dropping by a third over the past month. The ORTEX short score ticked down to 46 from around 50, ranking ZBRA in the 28th percentile for short pressure across its sector — consistent with a stock where the squeeze risk is limited and borrow is freely available. The contrast is worth naming: options traders turned bullish in one session, while a subset of short sellers held their ground.
The one area that doesn't yet confirm the enthusiasm is near-term EPS momentum. The factor score for 30-day earnings estimate revisions sits at just the 30th percentile, and the 90-day reading is only modestly better at 44. The 12-month forward EPS trajectory, however, ranks at the 95th percentile — the fundamental growth story is intact, but analysts haven't yet revised quarterly numbers aggressively in response to the print. Institutional holders heading into the result were concentrated: BlackRock held 8.8% as of June 30, adding 286,000 shares in the period, while Boston Partners added 288,000. Insiders were net sellers through May at prices well below today's level — the CEO sold 6,185 shares at $223.73 on May 4, now looking prescient in reverse — but those trades were routine compensation-related disposals with low significance scores rather than directional bets.
Close peer CGNX gained 18.5% on the week while AEVA added 39%, suggesting broader sector tailwinds that lifted the group. NOVT added 12.6%. The next Zebra earnings event is pencilled in for November 3, leaving the question of whether analyst targets — still clustered well below $455 at the bullish end — migrate higher as the new consensus forms.
See the live data behind this article on ORTEX.
Open ZBRA on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
